Cargando…

Synaptic roles for phosphomannomutase type 2 in a new Drosophila congenital disorder of glycosylation disease model

Congenital disorders of glycosylation (CDGs) constitute a rapidly growing family of human diseases resulting from heritable mutations in genes driving the production and modification of glycoproteins. The resulting symptomatic hypoglycosylation causes multisystemic defects that include severe neurol...

Descripción completa

Detalles Bibliográficos
Autores principales:	Parkinson, William M., Dookwah, Michelle, Dear, Mary Lynn, Gatto, Cheryl L., Aoki, Kazuhiro, Tiemeyer, Michael, Broadie, Kendal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Company of Biologists Ltd 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4892659/ https://www.ncbi.nlm.nih.gov/pubmed/26940433 http://dx.doi.org/10.1242/dmm.022939

Ejemplares similares

Overelaborated synaptic architecture and reduced synaptomatrix glycosylation in a Drosophila classic galactosemia disease model
por: Jumbo-Lucioni, Patricia, et al.
Publicado: (2014)

Yeast Models of Phosphomannomutase 2 Deficiency, a Congenital Disorder of Glycosylation
por: Lao, Jessica P., et al.
Publicado: (2018)

Temporal Requirements of the Fragile X Mental Retardation Protein in Modulating Circadian Clock Circuit Synaptic Architecture
por: Gatto, Cheryl L., et al.
Publicado: (2009)

Anesthetic management of a child with phosphomannomutase-2 congenital disorder of glycosylation (PMM2-CDG)
por: Sakai, Wataru, et al.
Publicado: (2017)

Genetic Controls Balancing Excitatory and Inhibitory Synaptogenesis in Neurodevelopmental Disorder Models
por: Gatto, Cheryl L., et al.
Publicado: (2010)

Conformational Response to Ligand Binding in Phosphomannomutase2: INSIGHTS INTO INBORN GLYCOSYLATION DISORDER
por: Andreotti, Giuseppina, et al.
Publicado: (2014)

Modeling Congenital Disorders of N-Linked Glycoprotein Glycosylation in Drosophila melanogaster
por: Frappaolo, Anna, et al.
Publicado: (2018)

Host protein glycosylation in nucleic acid vaccines as a potential hurdle in vaccine design for nonviral pathogens
por: Ozdilek, Ahmet, et al.
Publicado: (2020)

Fragile X mental retardation protein regulates trans-synaptic signaling in Drosophila
por: Friedman, Samuel H., et al.
Publicado: (2013)

Patient reported outcomes for phosphomannomutase 2 congenital disorder of glycosylation (PMM2-CDG): listening to what matters for the patients and health professionals
por: Pascoal, C., et al.
Publicado: (2022)

Phosphomannose isomerase inhibitors improve N-glycosylation in selected phosphomannomutase-deficient fibroblasts.
por: Sharma, Vandana, et al.
Publicado: (2011)

Cysteine mutations impair the structural stability of phosphomannomutase 2 (PMM2) in glycosylation-associated metabolic disorders
por: Pan, Yunfan, et al.
Publicado: (2022)

Fragile X Mental Retardation Protein Regulates Activity-Dependent Membrane Trafficking and Trans-Synaptic Signaling Mediating Synaptic Remodeling
por: Sears, James C., et al.
Publicado: (2018)

Activity-Dependent Modulation of Neural Circuit Synaptic Connectivity
por: Tessier, Charles R., et al.
Publicado: (2009)

Glycomic Characterization of Induced Pluripotent Stem Cells Derived from a Patient Suffering from Phosphomannomutase 2 Congenital Disorder of Glycosylation (PMM2-CDG)
por: Thiesler, Christina T., et al.
Publicado: (2016)

ESCRT-III Membrane Trafficking Misregulation Contributes To Fragile X Syndrome Synaptic Defects
por: Vita, Dominic J., et al.
Publicado: (2017)

Biochemical phenotype of a common disease-causing mutation and a possible therapeutic approach for the phosphomannomutase 2-associated disorder of glycosylation
por: Andreotti, Giuseppina, et al.
Publicado: (2013)

Electrophysiological Recording in the Drosophila Embryo
por: Chen, Kaiyun, et al.
Publicado: (2009)

Newly Identified Electrically Coupled Neurons Support Development of the Drosophila Giant Fiber Model Circuit
por: Kennedy, Tyler, et al.
Publicado: (2018)

Neural circuit architecture defects in a Drosophila model of Fragile X syndrome are alleviated by minocycline treatment and genetic removal of matrix metalloproteinase
por: Siller, Saul S., et al.
Publicado: (2011)

Harvesting and Preparing Drosophila Embryos for Electrophysiological Recording and Other Procedures
por: Featherstone, David E., et al.
Publicado: (2009)

A Targeted Glycan-Related Gene Screen Reveals Heparan Sulfate Proteoglycan Sulfation Regulates WNT and BMP Trans-Synaptic Signaling
por: Dani, Neil, et al.
Publicado: (2012)

FMRP activity and control of Csw/SHP2 translation regulate MAPK-dependent synaptic transmission
por: Leahy, Shannon N., et al.
Publicado: (2023)

Glycomics-informed glycoproteomic analysis of site-specific glycosylation for SARS-CoV-2 spike protein
por: Rosenbalm, Katelyn E., et al.
Publicado: (2020)

Neural and Synaptic Defects in slytherin, a Zebrafish Model for Human Congenital Disorders of Glycosylation
por: Song, Yuanquan, et al.
Publicado: (2010)

Glycosphingolipids are linked to elevated neurotransmission and neurodegeneration in a Drosophila model of Niemann Pick type C
por: Eberwein, Anna E., et al.
Publicado: (2023)

Impaired activity-dependent neural circuit assembly and refinement in autism spectrum disorder genetic models
por: Doll, Caleb A., et al.
Publicado: (2014)

Regulation of protein glycosylation and sorting by the Golgi matrix proteins GRASP55/65
por: Xiang, Yi, et al.
Publicado: (2013)

Phosphomannomutase deficiency (PMM2-CDG): ataxia and cerebellar assessment
por: Serrano, Mercedes, et al.
Publicado: (2015)

Hyperinsulinism May Be Underreported in Hypoglycemic Patients with Phosphomannomutase 2 Deficiency
por: Vurallı, Doğuş, et al.
Publicado: (2022)

Evolutionary rescue of phosphomannomutase deficiency in yeast models of human disease
por: Vignogna, Ryan C, et al.
Publicado: (2022)

Excess protein synthesis in Drosophila Fragile X mutants impairs long-term memory
por: Bolduc, François V., et al.
Publicado: (2008)

Heterodimerization of Two Pathological Mutants Enhances the Activity of Human Phosphomannomutase2
por: Andreotti, Giuseppina, et al.
Publicado: (2015)

Dietary mannose supplementation in phosphomannomutase 2 deficiency (PMM2-CDG)
por: Taday, Roman, et al.
Publicado: (2020)

Trypanosoma cruzi Phosphomannomutase and Guanosine Diphosphate-Mannose Pyrophosphorylase Ligandability Assessment
por: Zmuda, Filip, et al.
Publicado: (2019)

Phosphomannomutase 2 hyperinsulinemia: Recent advances of genetic pathogenesis, diagnosis, and management
por: Chen, Congli, et al.
Publicado: (2023)

Insights into complexity of congenital disorders of glycosylation
por: Goreta, Sandra Supraha, et al.
Publicado: (2012)

Treatment Options in Congenital Disorders of Glycosylation
por: Park, Julien H., et al.
Publicado: (2021)

Hemostatic defects in congenital disorders of glycosylation
por: Pascreau, Tiffany, et al.
Publicado: (2023)

Enzymatic and structural characterization of HAD5, an essential phosphomannomutase of malaria-causing parasites
por: Frasse, Philip M., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_52pis83m6714vajbbgrdc7prev